Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug
Aurobindo Pharma has received approval from USFDA to produce and trade Budesonide Inhalation Suspension
Aurobindo Pharma has received approval from USFDA to produce and trade Budesonide Inhalation Suspension
The pharma major has launched a novel fixed-dose triple drug combination ‘DIFIZMA’ to treat inadequately controlled asthma.